Genprex

Category: Blog Posts

Independent Researchers Reaffirm REQORSA’s Potential in Cancer, Suggest REQORSA May Benefit Other Diseases and Infections

A new study published in Cancer Gene Therapy by independent researchers outlines REQORSA as a promising therapeutic candidate for combinational therapy in cancer

Read More

Genprex’s REQORSA™ Immunogene Therapy: The First Systemic Gene Therapy Used for Cancer

Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, is a leader in gene therapy with a systemic gene therapy in development for non-small cell lung cancer (NSCLC).

Read More

Q&A with Mark Berger, M.D., Genprex’s Chief Medical Officer

Dr. Mark Berger is a senior executive with 25 years of biotech and pharmaceutical company experience in the development of oncology therapeutics.

Read More

Genprex’s Novel Immunogene Therapy in Lung Cancer Highlighted in Key Opinion Leader Event

Genprex’s lead drug candidate, REQORSA™ Immunogene Therapy that uses our proprietary, non-viral ONCOPREX® Nanoparticle Delivery System was highlighted in a Key Opinion Leader event hosted by Alliance Global Partners (AGP) for their institutional customers.

Read More

Genprex is on the Cutting Edge of Lung Cancer Treatment Development

Mr. Redman provides his reaction to a recent article in ONCOLOGY® and discusses how Genprex is harnessing breakthroughs in lung cancer treatment.

Read More

Genprex Honors June as Cancer Immunotherapy Month

Genprex is supporting The Society for Immunotherapy of Cancer (SITC) and the Cancer Research Institute’s Annual Cancer Immunotherapy Month in June.

Read More

Genprex’s Response to COVID-19 and its Business Operations

At Genprex, the health and well-being of the communities we serve, including those with cancer and diabetes, is our top priority.

Read More

Highlighting Genprex’s Medical Advisors on National Doctors’ Day

March 30 marks National Doctors’ Day, an annual holiday when we can all acknowledge and show appreciation for our physicians who help save lives everywhere.

Read More

The Power Behind Gene Therapy Drug Combinations

Genprex is harnessing the power of a combinational treatment approach to overcome treatment limitations and offer patients new treatment options.

Read More

Genprex is Pioneering the Use of Non-Viral Vectors in Gene Therapy

Genprex is once again leading the way in gene therapy and raising the standard in cancer treatment based upon its unique, proprietary technology platform that includes its non-viral vector nanoparticle delivery system.

Read More